MAPT and Alzheimer disease: AD patients frequently exhibit a gradual loss of brain cells and cognitive decline, accompanied by the abnormal accumulation of amyloid β (Aβ) plaques around or outside neurons, as well as the buildup of microtubule-associated protein Tau in cortical neuronal dendrites and axons [2-4].